HDAC9 and cancer: Based on the fact that HMTs and HDAC synergistically reverse drug resistance and the role of HMTs in tumor regulation, we propose a idea that there may be interactions between HMTs, or between HMTs and other molecular targets, it is important to clarify the interaction between those factors and design “a double-target drug” for the successful treatment of cancers.